# Early Diagnostic of Sepsis and Potential Impact on Antibiotic Management Based on Serial.Pancreatic Stone Protein (PSP) Measured Using the AbioScope.

> **NCT03474809** · — · COMPLETED · sponsor: **Abionic SA** · enrollment: 296 (actual)

## Conditions studied

- Sepsis

## Interventions

- **DEVICE:** Blood sampling

## Key facts

- **NCT ID:** NCT03474809
- **Lead sponsor:** Abionic SA
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-14
- **Primary completion:** 2019-03-15
- **Final completion:** 2019-03-15
- **Target enrollment:** 296 (ACTUAL)
- **Last updated:** 2019-08-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03474809

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03474809, "Early Diagnostic of Sepsis and Potential Impact on Antibiotic Management Based on Serial.Pancreatic Stone Protein (PSP) Measured Using the AbioScope.". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03474809. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*